TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02807454 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03707431 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT03707431 — Predictive Biomarker (PRD): MANF mRNA
Genes: MANF; ARMET; ARP
Study NCT01180166 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT01180166 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00213564 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00213564 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT00213564 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study NCT00213564 — Safety Biomarker (SAF): MMP-1
Genes: MMP1
Study NCT00068783 — Predictive Biomarker (PRD): PDGFRA mRNA
Genes: PDGFRA; PDGFR2; RHEPDGFRA
Study NCT03492151 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04089501 — Predictive Biomarker (PRD): NR1I2
Genes: ONR1; PXR; BXR; SXR; PAR2
Study NCT02473328 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01912872 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT00004498 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study NCT02800369 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT05222347 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05222347 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05222347 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02554851 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04150640 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03024437 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03024437 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03847467 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04385004 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT03052192 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00202137 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03301480 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03301480 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT03013179 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03875820 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT03875820 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT05400915 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05400915 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02884791 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT00212901 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02421939 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04388384 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04388384 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04388384 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04388384 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02672501 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05077878 — Predictive Biomarker (PRD): DSPP mRNA
Genes: DSPP
Study NCT02420977 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03799601 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT03799601 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02690480 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT02690480 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02690480 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04212702 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03579875 — Predictive Biomarker (PRD): BMF mRNA
Genes: BMF
Study NCT01902602 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04459663 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04459663 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04459663 — Predictive Biomarker (PRD): ROS1
Genes: MCF3; ROS; c-ros-1
Study NCT05541224 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT01783626 — Safety Biomarker (SAF): Beta-2-microglobulin
Genes: B2M; CDABP0092; HDCMA22P
Study NCT00720122 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06708247 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT02186080 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01729936 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03140865 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05447130 — Predictive Biomarker (PRD): PHEX mRNA
Genes: PHEX; PEX
Study NCT01199107 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01199107 — Safety Biomarker (SAF): BDNF
Study NCT04576767 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04576767 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04576767 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT01763203 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04317105 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT04317105 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT04228172 — Pharmacodynamic Biomarker (PDY): Lysosomal acid glucosylceramidase
Genes: GBA1; GBA; GC; GLUC
Study NCT02390427 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02390427 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT01865084 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT04380220 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Complement C3
Genes: C3; CPAMD1
Study NCT04380220 — Predictive Biomarker (PRD): C9 mRNA
Genes: C9
Study NCT04380220 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04380220 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study NCT03356587 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03356587 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT03356587 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03180957 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03283332 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02748824 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00096954 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT03698552 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT04899154 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT04899154 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00216021 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study NCT00756808 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT02546856 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02546856 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT02546856 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02298270 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study NCT00978432 — Predictive Biomarker (PRD): RRAD mRNA
Genes: RRAD; RAD
Study NCT04610242 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04610242 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT00130208 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00090051 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01805700 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02868749 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03900949 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT03900949 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT03283696 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study NCT02693717 — Predictive Biomarker (PRD): MTAP mRNA
Genes: MTAP; MSAP
Study NCT03675529 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01641315 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03654209 — Predictive Biomarker (PRD): APC mRNA
Genes: APC; DP2.5
Study NCT04962438 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04962438 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00050661 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT00836446 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01535469 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02944799 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01293396 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT04207567 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03976245 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02059408 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02754778 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04029688 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT04339166 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04935723 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01902420 — Predictive Biomarker (PRD): AIP mRNA
Genes: AIP; XAP2
Study NCT04241237 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04241237 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04278378 — Safety Biomarker (SAF): MTHFR
Study NCT00210119 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00210119 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00210119 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03184090 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03184090 — Predictive Biomarker (PRD): CDK6 mRNA
Genes: CDK6; CDKN6
Study NCT03184090 — Safety Biomarker (SAF): Cyclin-dependent kinase inhibitor 1
Genes: CDKN1A
Study NCT03184090 — Predictive Biomarker (PRD): CDKN1B mRNA
Genes: CDKN1B; KIP1; p27
Study NCT02166593 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00416637 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00611455 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02676310 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT02063880 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04343729 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01984593 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04158856 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00760214 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02005432 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03885011 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01674621 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00403026 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04075279 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00339703 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02818231 — Predictive Biomarker (PRD): CDX2 mRNA
Genes: CDX2; CDX3
Study NCT01938820 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00935220 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01603407 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT03652545 — Predictive Biomarker (PRD): WT1 mRNA
Genes: WT1
Study NCT03652545 — Predictive Biomarker (PRD): PRAME mRNA
Genes: PRAME; MAPE; OIP4
Study NCT00020930 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00020930 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04246671 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01596218 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT00630565 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04479280 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04444661 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02805218 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04673149 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01070043 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02199509 — Predictive Biomarker (PRD): OMD mRNA
Genes: OMD; SLRR2C; UNQ190/PRO216
Study NCT02765776 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02765776 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00351546 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT06188325 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02258906 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02258906 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT02297425 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02297425 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00398047 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05050552 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05050552 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01857193 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT01857193 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04634110 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03191240 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00208299 — Safety Biomarker (SAF): ADORA2A
Genes: RDC8
Study NCT03928145 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04407481 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01178073 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02583672 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02361060 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03304080 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03304080 — Predictive Biomarker (PRD): Hormone receptor
Study NCT03304080 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study NCT03304080 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT03356054 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT01302379 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00011193 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01429246 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04595240 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04595240 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT04171284 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT00423358 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05325814 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04592380 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03556683 — Predictive Biomarker (PRD): MCC mRNA
Genes: MCC
Study NCT01697527 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04093349 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT02772575 — Predictive Biomarker (PRD): EGR3 mRNA
Genes: EGR3; PILOT
Study NCT02976402 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01671085 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01602380 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00854763 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00960440 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02344693 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03125746 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03125746 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05808556 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03478761 — Predictive Biomarker (PRD): CYP24A1 mRNA
Genes: CYP24A1; CYP24
Study NCT03763201 — Predictive Biomarker (PRD): TNFRSF18 mRNA
Genes: TNFRSF18; AITR; GITR; UNQ319/PRO364
Study NCT03763201 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03114956 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT04300920 — Predictive Biomarker (PRD): TOLLIP mRNA
Genes: TOLLIP
Study NCT04300920 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00040261 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04438941 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02927808 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04371614 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03384849 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04485169 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01492114 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT01492114 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00815451 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00815451 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00230165 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04495764 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT01221675 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06709599 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04786301 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00393289 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04343885 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01157871 — Safety Biomarker (SAF): Fibroblast growth factor 1
Genes: FGF1
Study NCT00005655 — Safety Biomarker (SAF): Interleukin 12
Study NCT00005655 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT03236350 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02416687 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT00202683 — Safety Biomarker (SAF): Succinate dehydrogenase
Genes: SDHD
Study NCT02676154 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02084134 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT02084134 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00872170 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04023149 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01557868 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05120011 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01920009 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01920009 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT03027817 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03864172 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT01459237 — Predictive Biomarker (PRD): CRH mRNA
Genes: CRH
Study NCT01459237 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT01681784 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT01681784 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04226911 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01605396 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03204838 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT03204838 — Predictive Biomarker (PRD): IDH2 mRNA
Genes: IDH2
Study NCT00201292 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT02429596 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT04747574 — Predictive Biomarker (PRD): CD24 mRNA
Genes: CD24; CD24A
Study NCT03036306 — Predictive Biomarker (PRD): SCX mRNA
Genes: SCX; BHLHA41; BHLHA48; SCXA; SCXB
Study NCT01506414 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT03810339 — Predictive Biomarker (PRD): POLE mRNA
Genes: POLE; POLE1
Study NCT03810339 — Predictive Biomarker (PRD): POLD1 mRNA
Genes: POLD1; POLD
Study NCT03810339 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03810339 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT01323946 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04062877 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT02447770 — Surrogate Endpoint (SUR): Blood pressure